At the same time, KLF4 needs to maintain the expression of its downstream target E-cadherin to prevent the mesenchymal transformation of breast tumor epithelial cells, so as to play its role in inhibiting breast cancer metastasis [37]. Here, CDH1 is linked to breast carcinoma.